Cu(II) interaction with amyloid-β peptide: A review of neuroactive mechanisms in AD brains

Brain Research Bulletin

Volumn 82, Issue 5-6, 2010, Pages 235-242

  Lin, Chang Jun ^a   Huang, Han Chang ^a   Jiang, Zhao Feng ^a  

^a BEIJING UNION UNIVERSITY   (China)

Author keywords

Alzheimer's disease (AD); Amyloid precursor protein (APP); Amyloid peptide (A ); Copper; Reactive oxygen species (ROS); Signal pathway

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; CUPRIC ION; GLYCINATE COPPER; TAU PROTEIN; COPPER; PEPTIDE FRAGMENT;

ALZHEIMER DISEASE; BETA SHEET; BINDING AFFINITY; COPPER METABOLISM; HUMAN; METAL BINDING; NEUROTOXICITY; NONHUMAN; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REVIEW; ANIMAL; BRAIN; METABOLISM; PATHOLOGY;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BRAIN; COPPER; HUMANS; PEPTIDE FRAGMENTS; AMYLOID BETA-PEPTIDES;

EID: 77955088624     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2010.06.003     Document Type: Review

References (83)

1. Adlard P.A., Bush A.I. Metals and Alzheimer's disease. Journal of Alzheimers Disease 2006, 10:145-163.
2. Adlard P.A., Cherny R.A., Finkelstein D.I., Gautier E., Robb E., Cortes M., Volitakis I., Liu X., Smith J.P., Perez K., Laughton K., Li Q.X., Charman S.A., Nicolazzo J.A., Wilkins S., Deleva K., Lynch T., Kok G., Ritchie C.W., Tanzi R.E., Cappai R., Masters C.L., Barnham K.J., Bush A.I. Rapid restoration of cognition in alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Aβ. Neuron 2008, 59:43-55.
3. Atwood C., Moir R., Huang X., Scarpa R., Bacarra N., Romano D., Hartshorn M., Tanzi R., Bush A. Dramatic aggregation of Alzheimer Abeta by Cu (II) is induced by conditions representing physiological acidosis. Journal of Biological Chemistry 1998, 273:12817.
4. Avila J. Tau phosphorylation and aggregation in Alzheimer's disease pathology. FEBS Letters 2006, 580:2922-2927.
5. Barnham K., Haeffner F., Ciccotosto G., Curtain C., Tew D., Mavros C., Beyreuther K., Carrington D., Masters C., Cherny R. Tyrosine gated electron transfer is key to the toxic mechanism of Alzheimer's disease beta-amyloid. The FASEB Journal 2004, 04.
6. Barnham K., Ciccotosto G., Tickler A., Ali F., Smith D., Williamson N., Lam Y., Carrington D., Tew D., Kocak G. Neurotoxic, redox-competent Alzheimer's beta-amyloid is released from lipid membrane by methionine oxidation. Journal of Biological Chemistry 2003, 278:42959.
7. Baruch-Suchodolsky R., Fischer B. Soluble amyloid beta(1-28)-copper(I)/copper(II)/iron(II) complexes are potent antioxidants in cell-free systems. Biochemistry 2008, 47:7796-7806.
8. Bayer T.A., Schafer S., Simons A., Kemmling A., Kamer T., Tepest R., Eckert A., Schussel K., Eikenberg O., Sturchler-Pierrat C., Abramowski D., Staufenbiel M., Multhaup G. Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid A beta production in APP23 transgenic mice. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:14187-14192.
9. Brzyska M., Trzesniewska K., Wieckowska A., Szczepankiewicz A., Elbaum D. Elecrochemical and conformational consequences of copper (Cu-I and Cu-II) binding to beta-amyloid(1-40). Chemical Biological Chemistry 2009, 10:1045-1055.
10. Bush A.I., Tanzi R.E. Therapeutics for Alzheimer's disease based on the metal hypothesis. Neurotherapeutics 2008, 5:421-432.
11. Bush A.I. The metallobiology of Alzheimer's disease. Trends in Neurosciences 2003, 26:207-214.
12. Butterfield D.A., Reed T., Newman S.F., Sultana R. Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment. Free Radical Biology and Medicine 2007, 43:658-677.
13. Caragounis A., Du T., Fi G.F., Laughton K.M., Volitakis I., Sharples R.A., Cherny R.A., Masters C.L., Drew S.C., Hill A.F., Li Q.X., Crouch P.J., Barnham K.J., White A.R. Differential modulation of Alzheimer's disease amyloid beta-peptide accumulation by diverse classes of metal ligands. Biochemical Journal 2007, 407:435-450.
14. Cater M.A., McInnes K.T., Li Q.X., Volitakis I., Fontaine S.L.A., Mercer J.F.B., Bush A.I. Intracellular copper deficiency increases amyloid-β secretion by diverse mechanisms. Biochemical Journal 2008, 412:141-152.
15. Chan C.W., Dharmarajan A., Atwood C.S., Huang X.D., Tanzi R.E., Bush A.I., Martins R.N. Anti-apoptotic action of Alzheimer A beta. Alzheimers Reports 1999, 2:113-119.
16. Crouch P.J., Hung L.W., Adlard P.A., Cortes M., Lal V., Filiz G., Perez K.A., Nurjono M., Caragounis A., Du T., Laughton K., Volitakis I., Bush A.I., Li Q.X., Masters C.L., Cappai R., Cherny R.A., Donnelly P.S., White A.R., Barnham K.J. Increasing Cu bioavailability inhibits Abeta oligomers and tau phosphorylation. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:381-386.
17. Cutler R.G., Kelly J., Storie K., Pedersen W.A., Tammara A., Hatanpaa K., Troncoso J.C., Mattson M.P. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:2070-2075.
18. Damante C.A., Osz K., Nagy Z., Papalardo G., Grasso G., Impellizzeri G., Rizzarelli E., Sovago I. The metal loading ability of beta-amyloid n-terminus: a combined potentiometric and spectroscopic study of copper(II) complexes with beta-Amyloid(1-16), its short or mutated peptide fragments, and its polyethylene glycol (PEG)-ylated analogue. Inorganic Chemistry 2008, 47:9669-9683.
19. Donnelly P.S, Caragounis A., Du T., Laughton K.M., Volitakis I., Cherny R.A., Sharples R.A., Hill A.F., Li Q.X., Masters C.L., Barnham K.J., White A.R. Selective intracellular release of copper and zinc ions from bis (thiosemicarbazonato) complexes reduces levels of Alzheimer disease amyloid-beta peptide. Journal of Biological Chemistry 2008, 283:4568-4577.
20. Fischer B., Suchodolsky R. Aβ40, either soluble or aggregated, is a remarkably potent antioxidant in cell free oxidative systems. Biochemistry 2009, 25:25.
21. Garai K, Sengupta P., Sahoo B., Maiti S. Selective destabilization of soluble amyloid beta oligomers by divalent metal ions. Biochemical and Biophysical Research Communications 2006, 345:210-215.
22. Geng J., Yu H.J., Ren J.S., Qu X.G. Rapid label-free detection of metal-induced Alzheimer's amyloid beta peptide aggregation by electrochemical method. Electrochemistry Communications 2008, 10:1797-1800.
23. Glenner G.G., Wong C.W. Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochemical and Biophysical Research Communication 1984, 122:1131-1135.
24. Guilloreau L., Combalbert S., Sournia-Saquet A., Mazarguil H., Faller P. Redox chemistry of copper-amyloid-beta: the generation of hydroxyl radical in the presence of ascorbate is linked to redox-potentials and aggregation state. Chemical Biological Chemistry 2007, 8:1317-1325.
25. Ha C., Ryu J., Park C.B. Metal ions differentially influence the aggregation and deposition of Alzheimer's beta-amyloid on a solid template. Biochemistry 2007, 46:6118-6125.
26. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
27. Hayashi T., Shishido N., Nakayama K., Nunomura A., Smith M.A., Perry G., Nakamura M. Lipid peroxidation and 4-hydroxy-2-nonenal formation by copper ion bound to amyloid-beta peptide. Free Radical Biology and Medicine 2007, 43:1552-1559.
28. House E., Collingwood J., Khan A., Korchazkina O., Berthon G., Exley C. Aluminium, iron, zinc and copper influence the in vitro formation of amyloid fibrils of Abeta42 in a manner that may have consequences for metal chelation therapy in Alzheimer's disease. Journal of Alzheimers Disease 2004, 6:291-301.
29. House E., Mold M., Collingwood J., Baldwin A., Goodwin S., Exley C. Copper abolishes the beta-sheet secondary structure of preformed amyloid fibrils of amyloid-beta42. Journal of Alzheimers Disease 2009, 18:811-817.
30. Huang X., Atwood C.S., Moir R.D., Hartshorn M.A., Tanzi R.E., Bush A.I. Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Abeta peptides. Journal of Biological Inorganic Chemistry 2004, 9:954-960.
31. Indi S, Rao K. Copper-and iron-induced differential fibril formation in alpha-synuclein: TEM study. Neuroscience Letters 2007, 424:78-82.
32. Jiao Y., Yang P. Mechanism of copper (II) inhibiting Alzheimer's amyloid beta-peptide from aggregation: a molecular dynamics investigation. Journal of Physical Chemistry B 2007, 111:7646-7655.
33. Jones C., Abdelraheim S., Brown D., Viles J. Preferential Cu2+ coordination by His96 and His111 induces beta-sheet formation in the unstructured amyloidogenic region of the prion protein. Journal of Biological Chemistry 2004, 279:32018.
34. Karr J.W., Kaupp L.J., Szalai V.A. Amyloid-beta binds Cu2+ in a mononuclear metal ion-binding site. Journal of American Chemical Society 2004, 126:13534-13538.
35. Kastenholz B., Garfin D. Medicinal plants: a natural chaperones source for treating neurological disorders. Protein and Peptide Letters 2009, 16:116-120.
36. Kessler H., Pajonk F.G., Meisser P., Schneider-Axmann T., Hoffmann K.H., Supprian T., Herrmann W., Obeid R., Multhaup G., Falkai P., Bayer T.A. Cerebrospinal fluid diagnostic markers correlate with lower plasma copper and ceruloplasmin in patients with Alzheimer's disease. Journal of Neural Transmission 2006, 113:1763-1769.
37. Kessler H., Bayer T.A., Bach D., Schneider-Axmann T., Supprian T., Herrmann W., Haber M., Multhaup G., Falkai P., Pajonk F.G. Intake of copper has no effect on cognition in patients with mild Alzheimer's disease: a pilot phase 2 clinical trial. Journal of Neural Transmission 2008, 115:1181-1187.
38. Klein W.L., Stine W.B., Teplow D.B. Small assemblies of unmodified amyloid [beta]-protein are the proximate neurotoxin in Alzheimer's disease. Neurobiology of Aging 2004, 25:569-580.
39. Kong G.K.W., Adams J.J., Harris H.H., Boas J.F., Curtain C.C., Galatis D., Masters C.L., Barnham K.J., McKinstry W.J., Cappai R., Parker M.W. Structural Studies of the alzheimer's amyloid precursor protein copper-binding domain reveal how it binds copper Ions. Journal of Molecular Biology 2007, 367:148-161.
40. Kontush A. Alzheimer's amyloid-beta as a preventive antioxidant for brain lipoproteins. Cellular and Molecular Neurobiology 2001, 21:299-315.
41. Kontush A., Donarski N., Beisiegel U. Resistance of human cerebrospinal fluid to in vitro oxidation is directly related to its amyloid-beta content. Free Radical Research 2001, 35:507-517.
42. Lannfelt L., Blennow K., Zetterberg H., Batsman S., Ames D., Harrison J., Masters C.L., Targum S., Bush A.I., Murdoch R., Wilson J., Ritchie C.W. Safety efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double blind, randomised, placebo-controlled trial. The Lancet Neurology 2008, 7:779-786.
43. Lim K.H, Kim Y.K., Chang Y.T. Investigations of the molecular mechanism of metal-induced A beta (1-40) amyloidogenesis. Biochemistry 2007, 46:13523-13532.
44. Lin R.Z., Chen X.H., Li W.M., Han Y.F., Liu P.Q., Pi R.B. Exposure to metal ions regulates mRNA levels of APP and BACE1 in PC12 cells: Blockage by curcumin. Neuroscience Letters 2008, 440:344-347.
45. Lu J., Wu D.m., Zheng Y.l., Sun D.x., Hu B., Shan Q., Zhang Z.f., Fan S.h. Trace amounts of copper exacerbate beta amyloid-induced neurotoxicity in the cholesterol-fed mice through TNF-mediated inflammatory pathway. Brain, Behavior, and Immunity 2009, 23:193-203.
46. Maiti N.C., Jiang D.L., Wain A.J., Patel S., Dinh K.L., Zhou F.M. Mechanistic studies of Cu(II) binding to amyloid-beta peptides and the fluorescence and redox behaviors of the resulting complexes. Journal of Physical Chemistry B 2008, 112:8406-8411.
47. Mantri Y., Fioroni M., Baik M.H. Computational study of the binding of Cu-II to Alzheimer's amyloid-beta peptide: do A beta 42 and A beta 40 bind copper in identical fashion. Journal of Biological Inorganic Chemistry 2008, 13:1197-1204.
48. Mare S., Penugonda S., Robinson S.M., Dohgu S., Banks W.A., Ercal N. Copper complexing decreases the ability of amyloid beta peptide to cross the BBB and enter brain parenchyma. Peptides 2007, 28:1424-1432.
49. Masters C.L., Simms G., Weinman N.A., Multhaup G., McDonald B.L., Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proceedings of the National Academy of Sciences of the United States of America 1985, 82:4245-4249.
50. Matsuzaki S., Yasuda Y., Kobayashi S., Koyama Y., Kawamoto K., Katayama T., Tohyama M. Monomeric A beta and metals reduce their cytotoxicities to each other. Biochemical and Biophysical Research Communications 2007, 358:540-544.
51. Maynard C.J., Bush A.I., Masters C.L., Cappai R., Li Q.X. Metals and amyloid-beta in Alzheimer's disease. International Journal Experimental Pathology 2005, 86:147-159.
52. Maynard C.J., Cappai R., Volitakis I., Laughton K.M., Masters C.L., Bush A.I., Li Q.X. Chronic exposure to high levels of zinc or copper has little effect on brain metal homeostasis or Aβ accumulation in transgenic APP-C100 mice. Cellular and Molecular Neurobiology 2009, 1-11.
53. Minicozzi V., Stellato F., Comai M., Serra M.D., Potrich C., Meyer-Klaucke W., Morante S. Identifying the minimal copper- and zinc-binding site sequence in amyloid-beta peptides. Journal of Biological Chemistry 2008, 283:10784-10792.
54. Miura T., Suzuki K., Kohata N., Takeuchi H. Metal binding modes of Alzheimer's amyloid beta-peptide in insoluble aggregates and soluble complexes. Biochemistry 2000, 39:7024-7031.
55. Murariu M., Dragan E.S., Drochioiu G. Synthesis and mass spectrometric characterization of a metal-affinity decapeptide: copper-induced conformational changes. Biomacromolecules 2007, 8:3836-3841.
56. Murray I.V., Sindoni M.E., Axelsen P.H. Promotion of oxidative lipid membrane damage by amyloid beta proteins. Biochemistry 2005, 44:12606-12613.
57. Nakamura M., Shishido N., Nunomura A., Smith M.A., Perry G., Hayashi Y., Nakayama K., Hayashi T. Three histidine residues of amyloid-beta peptide control the redox activity of copper and iron. Biochemistry 2007, 46:12737-12743.
58. Nunomura A., Perry G., Aliev G., Hirai K., Takeda A., Balraj E.K., Jones P.K., Ghanbari H., Wataya T., Shimohama S., Chiba S., Atwood C.S., Petersen R.B., Smith M.A. Oxidative damage is the earliest event in Alzheimer disease. Journal of Neuropathology and Experimental Neurology 2001, 60:759-767.
59. Opazo C., Huang X., Cherny R.A., Moir R.D., Roher A.E., White A.R., Cappai R., Masters C.L., Tanzi R.E., Inestrosa N.C., Bush A.I. Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2). Journal of Biological Chemistry 2002, 277:40302-40308.
60. Pradines V., Stroia A.J., Faller P. Amyloid fibrils: modulation of formation and structure by copper (II). New Journal of Chemistry 2008, 32:1189-1194.
61. Price K.A., Filiz G., Caragounis A., Du T., Laughton K.M., Masters C.L., Sharples R.A., Hill A.F., Li Q.X., Donnelly P.S., Barnham K.J., Crouch P.J., White A.R. Activation of epidermal growth factor receptor by metal-ligand complexes decreases levels of extracellular amyloid beta peptide. International Journal of Biochemistry and Cell Biology 2008, 40:1901-1917.
62. Rajendran R., Ren M.Q., Ynsa M.D., Casadesus G., Smith M.A., Perry G., Halliwell B., Watt F. A novel approach to the identification and quantitative elemental analysis of amyloid deposits-Insights into the pathology of Alzheimer's disease. Biochemical and Biophysical Research Communications 2009, 382:91-95.
63. Ritchie C., Bush A., Mackinnon A., Macfarlane S., Mastwyk M., MacGregor L., Kiers L., Cherny R., Li Q., Tammer A. Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting A {beta} amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Archives of Neurology 2003, 60:1685.
64. Ryu J., Girigoswami K., Ha C., Ku S.H., Park C.B. Influence of multiple metal ions on beta-amyloid aggregation and dissociation on a solid surface. Biochemistry 2008, 47:5328-5335.
65. Shearer J., Szalai V.A. The amyloid-beta peptide of alzheimer's disease binds Cu-I in a Linear Bis-His coordination environment: insight into a possible neuroprotective mechanism for the amyloid-beta peptide. Journal of the American Chemical Society 2008, 130:17826-17835.
66. Shin B.K., Saxena S. Direct evidence that all three histidine residues coordinate to Cu (II) in amyloid-beta (1-16). Biochemistry 2008, 47:9117-9123.
67. Smith D.G., Cappai R., Barnham K.J. The redox chemistry of the Alzheimer's disease amyloid beta peptide. Biochimica Et Biophysica Acta-Biomembranes 2007, 1768:1976-1990.
68. Smith D.P., Smith D.G., Curtain C.C., Boas J.F., Pilbrow J.R., Ciccotosto G.D., Lau T.L., Tew D.J., Perez K., Wade J.D., Bush A.I., Drew S.C., Separovic F., Masters C.L., Cappai R., Barnham K.J. Copper-mediated amyloid-beta toxicity is associated with an intermolecular histidine bridge. Journal of Biological Chemistry 2006, 281:15145-15154.
69. Smith D.P., Ciccotosto G.D., Tew D.J., Fodero-Tavoletti M.T., Johanssen T., Masters C.L., Barnham K.J., Cappai R. Concentration dependent Cu2+ induced aggregation and dityrosine formation of the Alzheimer's disease amyloid-beta peptide. Biochemistry 2007, 46:2881-2891.
70. Smorgon C., Mari E., Atti A., DALLA N. Trace elements and cognitive impairment: an elderly cohort study. Archives of Gerontology and Geriatrics 2004, 38:393-402.
71. Sparks D., Schreurs B. Trace amounts of copper in water induce beta-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:11065.
72. Spisni E., Valerii M.C., Manerba M., Strillacci A., Polazzi E., Mattia T., Griffoni C., Tomasi V. Effect of copper on extracellular levels of key pro-inflammatory molecules in hypothalamic GN11 and primary neurons. NeuroToxicology 2009, 30:605-612.
73. Squitti R., Lupoi D., Pasqualetti P., Dal Forno G., Vernieri F., Chiovenda P., Rossi L., Cortesi M., Cassetta E., Rossini P. Elevation of serum copper levels in Alzheimer's disease. Neurology 2002, 59:1153.
74. Squitti R., Ventriglia M., Barbati G., Cassetta E., Ferreri F., Dal Forno G., Ramires S., Zappasodi F., Rossini P. Free copper in serum of Alzheimer's disease patients correlates with markers of liver function. Journal of Neural Transmission 2007, 114:1589-1594.
75. Strozyk D., Launer L.J., Adlard P.A., Cherny R.A., Tsatsanis A., Volitakis I., Blennow K., Petrovitch H., White L.R., Bush A.I. Zinc and copper modulate Alzheimer Aβ levels in human cerebrospinal fluid. Neurobiology of Aging 2009, 30:1069-1077.
76. Syme C., Nadal R., Rigby S., Viles J. Copper binding to the amyloid- {beta}(A {beta}) peptide associated with Alzheimer's disease: folding, coordination geometry, pH dependence, stoichiometry, and affinity of Abeta- (1-28): insights from a range of complementary spectroscopic techniques. Journal of Biological Chemistry 2004, 279:18169.
77. Talmard C, Guilloreau L., Coppel Y., Mazarguil H., Faller P. Amyloid-beta peptide forms monomeric complexes with Cu-II and Zn-II prior to aggregation. Chemical Biological Chemistry 2007, 8:163-165.
78. White A.R., Du T., Laughton K.M., Volitakis I., Sharples R.A., Xilinas M.E., Hoke D.E., Holsinger R.M., Evin G., Cherny R.A., Hill A.F., Barnham K.J., Li Q.X., Bush A.I., Masters C.L. Degradation of the Alzheimer disease amyloid beta-peptide by metal-dependent up-regulation of metalloprotease activity. Journal Biollogical Chemistry 2006, 281:17670-17680.
79. Wu W., Silbajoris R.A., Whang Y.E., Graves L.M., Bromberg P.A., Samet J.M. p38 and EGF receptor kinase-mediated activation of the phosphatidylinositol 3-kinase/Akt pathway is required for Zn2+-induced cyclooxygenase-2 expression. American Journal of Physiology Lung Cellular and Molecular Physiology 2005, 289:L883-889.
80. Yang X.H., Huang H.C., Chen L., Xu W., Jiang Z.F. Coordinating to three histidine residues: cu (ii) promotes oligomeric and fibrillar amyloid-beta peptide to precipitate in a non-beta aggregation manner. Jounal of Alzheimers Disease 2009, 18:799-810.
81. Yoshiike Y., Tanemura K., Murayama O., Akagi T., Murayama M., Sato S., Sun X.Y., Tanaka N., Takashima A. New insights on how metals disrupt amyloid beta-aggregation and their effects on amyloid-beta cytotoxicity. Journal of Biological Chemistry 2001, 276:32293-32299.
82. Yu H.J., Ren J.S., Qu X.G. Different hydration changes accompanying copper and zinc binding to amyloid beta-peptide: Water contribution to metal binding. Chemical Biological Chemistry 2008, 9:879-882.
83. Zou K., Gong J.S., Yanagisawa K., Michikawa M. A novel function of monomeric amyloid beta-protein serving as an antioxidant molecule against metal-induced oxidative damage. Journal of Neuroscience 2002, 22:4833-4841.